A Study to Develop Additional Safety and Clinical Experience With NATRECOR® hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels.
This study has been completed.
Study NCT00271557.
Last updated on May 8, 2009.
Information provided by Scios, Inc.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
